Home » MIVT Expands Delivery Systems With Two New Patents
MIVT Expands Delivery Systems With Two New Patents
MIV Therapeutics, a developer of next-generation biocompatible coatings and drug delivery technologies, has filed two new patent applications that will enable the development and manufacture of an advanced new class of drug-eluting coatings capable of delivering multiple medicines from a cardiovascular stent or other implanted medical devices. The new patent applications expand MIVT's proprietary biocompatible coating technology platform, upon which the company is developing a line of advanced stents that are expected to offer improved therapeutic functionality and patient health.
TMCnet.com (http://www.tmcnet.com/usubmit/2005/apr/1132249.htm)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May